Position in RLYB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,715,721
+$2,467,108 QoQ
Shares Held
302,756
+229.3% QoQ
Ownership
5.70%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLYB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,352,234 | $100,714,388 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,506,152 | $67,615,980 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,820,013 | $44,417,673 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,002,701 | $15,260,581 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
|
4,900,888 | $14,751,672 | |
| 6 | IMUX |
Immunic, Inc.
|
610,326 | $9,380,710 | |
| 7 | AARD |
Aardvark Therapeutics, Inc.
|
1,034,459 | $5,958,483 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $5,306,601 |
All Filings in RLYB
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0 | 0 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,715,721 | 302,756 | Shares | Sole | 2026-04-29 | |
| 2026-03-31 | $2,715,721 | 302,756 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $248,613 | 735,543 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $481,780 | 735,543 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $706,121 | 735,543 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $860,585 | 735,543 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,049,743 | 783,391 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,449,273 | 783,391 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,872,304 | 783,391 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,640,027 | 783,391 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,433,993 | 783,391 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,473,162 | 783,391 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,146,221 | 783,291 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,816,940 | 402,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,035,100 | 402,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,792,000 | 400,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,816,000 | 400,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,032,000 | 400,000 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||